# Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.

> **NCT02981576** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Jordan** · enrollment: 14 (actual)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **BIOLOGICAL:** Autologous Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT02981576
- **Lead sponsor:** University of Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-05-05
- **Final completion:** 2019-01-20
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02981576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02981576, "Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02981576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*